- •Unplanned pregnancies in women with congenital heart disease.
- •Adverse events from oral contraception.
- •Contraception counseling.
- •Complex congenital heart disease thrombotic risk substrates.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium.Circulation. 2010; 122: 2264-2271
- ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to Develop Guidelines for the Management of Adults with Congenital Heart Disease): developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.Circulation. 2008; 118: e714-e833
- Congenital heart disease in the general population: changing prevalence and age distribution.Circulation. 2007; 115: 163-172
- Pregnancy outcomes after the Fontan repair.J Am Coll Cardiol. 1996; 28: 763-767
- Pregnancy outcomes after atrial repair for transposition of the great arteries.Am J Cardiol. 2006; 98: 668-672
- The ROPAC registry: a multicentre collaboration on pregnancy outcomes in women with heart disease.Eur Heart J. 2013; 34: 634-635
- Pregnancy outcomes in women with transposition of the great arteries and arterial switch operation.Am J Cardiol. 2010; 106: 417-420
- Reproductive and contraceptive counseling received by adult women with congenital heart disease: a risk-based analysis.Congenit Heart Dis. 2013; 8: 20-31
- Contraception in women with congenital heart disease.Am J Cardiol. 2010; 106: 1317-1321
- Risks of contraception and pregnancy in heart disease.Heart. 2006; 92: 1520-1525
- Choosing the best contraceptive method for the adult with congenital heart disease.Curr Cardiol Rep. 2009; 11: 298-305
- U.S. medical eligibility criteria for contraceptive use 2010.(Adapted from the WHO Medical Eligibility Criteria for Contraceptive Use)2010
- Practice bulletin no. 121: long-acting reversible contraception: implants and intrauterine devices.Obstet Gynecol. 2011; 118: 184-196
- Current contraceptive status among women aged 15–44: United States, 2011–2013.NCHS Data Brief. 2014; 173: 1-8
- Marital status and female and male contraceptive sterilization in the United States.Fertil Steril. 2015; 103: 1509-1515
- Intended and unintended births in the United States: 1982–2010.National Health Statistics Reports. 2012; 55: 1-28
- Centers for Disease Control and Prevention, National Center for Health Statistics, Vital & Health Statistics: Use of Contraception in the U.S.: 1982-2008, Series 23, Number 29.2010
- Hormonal contraceptives and arterial thrombosis—not risk-free but safe enough.N Engl J Med. 2012; 336: 2316-2318
- Usefulness of progesterone-only components for contraception in patients with congenital heart disease.Am J Cardiol. 2013; 112: 590-593
- Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation.Int J Cardiol. 2013; 168: 3940-3943
- Dextro-transposition of the great arteries: long-term sequelae of atrial and arterial switch.Cardiol Clin. 2015; 33: 543-558
See page 914 for disclosure information.